2-Amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile | CAS:675126-27-9

We serve 2-Amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile CAS:675126-27-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile

Chemical Name:2-Amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile
CAS.NO:675126-27-9
Synonyms:2-amino-4-methoxy-5-(3-morpholin-4-ylpropoxy)benzonitrile
Molecular Formula:C15H21N3O3
Molecular Weight:291.34600
 
Physical and Chemical Properties:
Density:1.214
Boiling point:497.986ºC
Flash point:254.973ºC
 
Specification:
Appearance:Brown oil or off-white solid
Purity(HPLC):≥98.0%
Moisture:≤1.0%
Residue on ignition:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Gefitinib
 
Note:The product under valid patents will not be offered to the countries covered by patents.



Contact us for information like 2-Amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-amino-4-methoxy-5-(3-morpholin-4-ylpropoxy)benzonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile Use and application,2-Amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile technical grade,usp/ep/jp grade.


Related News: In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired.trimethyl benzene-1,3,5-tricarboxylate manufacturer In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired.N,N-diphenylimidazole-1-carboxamide supplier From the perspective of product structure, the varieties of these enterprises are mainly concentrated in vitamins, antipyretics and analgesics, antibiotics and corticosteroids (ie bulk drug substances).flucytosine vendor Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity.Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity.